Capricor Therapeutics
CAPR
#6000
Rank
S$1.47 B
Marketcap
S$25.41
Share price
-0.66%
Change (1 day)
206.20%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2026 (TTM): -S$0.15 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$0.14 Billion a decrease over its 2024 earnings that were of -S$52.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.15 Billion8.44%
2025 -S$0.14 Billion159.57%
2024 -S$52.21 Million81.57%
2023 -S$28.76 Million-23.2%
2022 -S$37.44 Million44.93%
2021 -S$25.84 Million46.61%
2020 -S$17.62 Million78.71%
2019 -S$9.86 Million-49.7%
2018 -S$19.6 Million-724.78%
2017 S$3.13 M-112.93%
2016 -S$24.27 Million46.27%
2015 -S$16.59 Million106.82%
2014 -S$8.03 Million-48.41%
2013 -S$15.55 Million977.23%
2012 -S$1.45 Million-77.11%
2011 -S$6.31 Million-22.35%
2010 -S$8.12 Million-20.17%
2009 -S$10.18 Million-41.17%
2008 -S$17.29 Million41.05%
2007 -S$12.26 Million1098.87%
2006 -S$1.03 Million4101.55%
2005 -S$0.03 Million-0.97%
2004 -S$0.03 Million17.87%
2003 -S$0.03 Million3.66%
2002 -S$0.03 Million-30.11%
2001 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.51 B-22,770.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.03 B-797.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.08 Billion 623.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.4 Billion 169.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$8.06 Million-94.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$19.25 Million-86.98%๐Ÿ‡บ๐Ÿ‡ธ USA